◆ 会议时间：2023年7月8日至12日
◆ 会议地点：加拿大 蒙特利尔

◆ 会议简介：

2023年第11届美国头颈学会(AHNS)头颈癌国际大会将于2023年7月8日至12日在加拿大蒙特利尔举行。
美国头颈学会(AHNS)由头颈外科医师学会(SHNS，成立于1954年)和美国头颈外科协会(ASHNS，成立于1958年)于1998年合并而来，是北美地区旨在促进头颈部肿瘤学研究和教育发展宣的最大单一组织。AHNS的宗旨是提供先进的教育、研究以及为头颈肿瘤患者提供优质的护理。未经本站许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com）

AHNS 11th International Conference on Head and Neck Cancer
Date: July 8-12, 2023
Venue: The Palais des congrès, Montréal, QC Canada

Organized by: American Head and Neck Society (AHNS)

Thene: Welcoming Back the World: Striving for Innovation, Quality, Compassion, and Collegiality

摘要征文投稿：

Submission Deadline: Friday, December 2, 2022, 5:00 PM EST

点此提交摘要>>>Submit Abstract>>>

The Scientific Program Service and Scientific Review Committee will be responsible for selecting oral and poster presentations. Oral presentations will be presented throughout the main scientific session and a short video may be incorporated into an oral podium presentation. Accepted abstracts may be published in the Final Program, on the AHNS website and on the JAMA Otolaryngology – Head & Neck Surgery website.

• No Previously Published/Presented Submissions (Encore Abstracts): The abstract submitted must present original work that has not and will not be presented prior to the AHNS 11th International Conference on Head and Neck Cancer.
• No Previously Published Submissions/No Submissions Under Consideration For Publication: The abstract submitted must present original work that has not and will not be published or presented prior to the AHNS 11th International Conference on Head and Neck Cancer, and is not currently under review for publication except by permission from the AHNS Program Chair. The exception to this rule is that a manuscript may be submitted to JAMA Otolaryngology – Head & Neck Surgery for special meeting related consideration only after the abstract has been accepted by AHNS for presentation. Manuscripts may not be submitted to any journals for consideration until after AHNS abstract acceptance notification. If the manuscript has been submitted to any journal prior to AHNS abstract acceptance notifications, the Abstract Submitter, Presenter and Senior Author will forfeit the privilege to submit, present, or be listed as an author on abstracts for the 2024 and 2025 AHNS Annual Meetings.
• Trials in Progress and Case Reports may be submitted
• Abstract submissions are limited to 500 words or less
• Images are allowed with abstract submissions. Images must be no larger than 1MB in file size, and no larger than 900 pixels wide by 900 pixels high
• No reference to the authors or the institution should appear within the body of the abstract or in the abstract title
• Abstracts can be edited until the submission site closes. After the submission site closes and the abstracts go into review, the content of the abstracts may not be edited in any way. Please make sure to proof read and double check your abstracts before submission. In addition, AHNS cannot update the content/text of your abstract to include new/updated data after acceptance notifications, although you will be allowed to include these updated findings in your actual presentation.

Authors are asked to choose the topic that best matches the content of their abstract:

• Cancer Biology
• Education/Care Delivery
• Endocrine Surgery
• Functional Outcomes/Quality
• Hypopharynx/Larynx
• Imaging and Screening
• Immunotherapy/Systemic Therapy
• Nasopharynx/Paranasal Sinus/Skull Base
• Oral Cavity
• Oropharynx/HPV Related Disease
• Radiation/Adjuvant Treatment
• Reconstruction/Microvascular Surgery
• Salivary Gland
• Skin Cancers

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。